Literature DB >> 3815028

Present status of pharyngogastric anastomosis following pharyngolaryngo-oesophagectomy.

K H Lam, T K Choi, W I Wei, W F Lau, J Wong.   

Abstract

Pharyngolaryngo-oesophagectomy with pharyngogastric anastomosis was described more than 25 years ago. Since then it has been employed for the treatment of cancers of the hypopharynx, cervical oesophagus and larynx. Results of recent reports showed a wide variability. Our previous report of 157 such operations gave a significant morbidity and overall hospital mortality rate of 31 per cent. In the 6-year period between 1980 and 1985, 91 patients underwent this operation. The morbidity and mortality rates gradually decreased to 30 and 5 per cent respectively. Changes in the indications for the operation resulted in a reduction in the number of procedures performed in recent years. Resection of the oesophagus for cancers of the pharyngolaryngeal region is indicated only when there is actual oesophageal involvement, and would be the prime indication of pharyngogastric anastomosis.

Entities:  

Mesh:

Year:  1987        PMID: 3815028     DOI: 10.1002/bjs.1800740218

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  4 in total

1.  MR imaging for predicting neoplastic invasion of the cervical esophagus.

Authors:  S Roychowdhury; L A Loevner; D M Yousem; A Chalian; K T Montone
Journal:  AJNR Am J Neuroradiol       Date:  2000-10       Impact factor: 3.825

2.  [Resection of esophageal cancer without thoracotomy by manual dissection and eversion stripping].

Authors:  J M Müller; U Zieren; A S Jerke; C Jacobi; M Adili; H Pichlmaier
Journal:  Langenbecks Arch Chir       Date:  1992

3.  Current management of cervical esophageal cancer.

Authors:  Daniel King Hung Tong; Simon Law; Dora Lai Wan Kwong; William I Wei; Raymond Wai Man Ng; Kam Ho Wong
Journal:  World J Surg       Date:  2011-03       Impact factor: 3.352

4.  Management of hypopharyngeal carcinoma: a 6-year review.

Authors:  R G Wight; M A Birchall; N D Stafford; R L Stanbridge
Journal:  J R Soc Med       Date:  1992-09       Impact factor: 18.000

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.